Jack L. Spurbeck

1.3k total citations
25 papers, 1.0k citations indexed

About

Jack L. Spurbeck is a scholar working on Genetics, Genetics and Hematology. According to data from OpenAlex, Jack L. Spurbeck has authored 25 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Genetics, 8 papers in Genetics and 8 papers in Hematology. Recurrent topics in Jack L. Spurbeck's work include Genomic variations and chromosomal abnormalities (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Myeloid Leukemia Research (5 papers). Jack L. Spurbeck is often cited by papers focused on Genomic variations and chromosomal abnormalities (7 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Acute Myeloid Leukemia Research (5 papers). Jack L. Spurbeck collaborates with scholars based in United States, United Kingdom and Poland. Jack L. Spurbeck's co-authors include Gordon W. Dewald, Syed M. Jalal, Alan R. Zinsmeister, Richard J. Dahl, Hymie Gordon, William A. Wyatt, Richard T. Silver, Eric R. Christensen, J. Aidan Carney and Judith E. Allen and has published in prestigious journals such as Science, Blood and Cancer.

In The Last Decade

Jack L. Spurbeck

25 papers receiving 974 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jack L. Spurbeck United States 17 342 330 330 244 164 25 1.0k
Sabrina Tosi United Kingdom 20 578 1.7× 550 1.7× 205 0.6× 180 0.7× 91 0.6× 52 1.1k
Josette Derré France 20 510 1.5× 662 2.0× 217 0.7× 94 0.4× 66 0.4× 47 1.4k
Sheila N.J. Sait United States 20 511 1.5× 510 1.5× 181 0.5× 206 0.8× 40 0.2× 72 1.2k
A J Carroll United States 17 873 2.6× 703 2.1× 281 0.9× 283 1.2× 63 0.4× 32 1.8k
Gordon W. Dewald United States 13 301 0.9× 317 1.0× 145 0.4× 325 1.3× 34 0.2× 18 683
Jacqueline R. Batanian United States 15 113 0.3× 206 0.6× 186 0.6× 82 0.3× 104 0.6× 56 568
Carin Lassen Sweden 21 570 1.7× 642 1.9× 122 0.4× 297 1.2× 28 0.2× 35 1.3k
Ilse Chudoba Germany 16 91 0.3× 436 1.3× 410 1.2× 57 0.2× 222 1.4× 36 858
Zuzana Zemanová Czechia 22 987 2.9× 744 2.3× 208 0.6× 434 1.8× 46 0.3× 139 1.7k
Sverre Heim Sweden 14 200 0.6× 278 0.8× 143 0.4× 65 0.3× 22 0.1× 16 706

Countries citing papers authored by Jack L. Spurbeck

Since Specialization
Citations

This map shows the geographic impact of Jack L. Spurbeck's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jack L. Spurbeck with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jack L. Spurbeck more than expected).

Fields of papers citing papers by Jack L. Spurbeck

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jack L. Spurbeck. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jack L. Spurbeck. The network helps show where Jack L. Spurbeck may publish in the future.

Co-authorship network of co-authors of Jack L. Spurbeck

This figure shows the co-authorship network connecting the top 25 collaborators of Jack L. Spurbeck. A scholar is included among the top collaborators of Jack L. Spurbeck based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jack L. Spurbeck. Jack L. Spurbeck is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dingli, David, Francis Grand, Jack L. Spurbeck, et al.. (2005). Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia. British Journal of Haematology. 130(2). 229–232. 24 indexed citations
2.
Spurbeck, Jack L., et al.. (2004). Primer on Medical Genomics Part XI: Visualizing Human Chromosomes. Mayo Clinic Proceedings. 79(1). 58–75. 16 indexed citations
3.
Spurbeck, Jack L., et al.. (2004). Hematologic malignancies, critical genes and representative pictures for 166 chromosome anomalies. Leukemia Research. 28(12). 1351–1356. 5 indexed citations
4.
Dewald, Gordon W., William A. Wyatt, Alan R. Zinsmeister, et al.. (1998). Highly Sensitive Fluorescence In Situ Hybridization Method to Detect Double BCR/ABL Fusion and Monitor Response to Therapy in Chronic Myeloid Leukemia. Blood. 91(9). 3357–3365. 4 indexed citations
5.
Knutsen, Turid, et al.. (1997). The AGT cytogenics laboratory manual. 2 indexed citations
6.
Schröck, Evelin, Timothy Veldman, Hesed Padilla‐Nash, et al.. (1997). Spectral karyotyping refines cytogenetic diagnostics of constitutional chromosomal abnormalities. Human Genetics. 101(3). 255–262. 129 indexed citations
7.
Spurbeck, Jack L., et al.. (1996). Dynamics of chromosome spreading. American Journal of Medical Genetics. 61(4). 387–393. 49 indexed citations
8.
Tefferi, Ayalew, et al.. (1995). Fluorescent in situ hybridization studies of lymphocytes and neutrophils in chronic granulocytic leukemia. Cancer Genetics and Cytogenetics. 83(1). 61–64. 23 indexed citations
9.
Dewald, Gordon W., Eric R. Christensen, Andreas Tiede, et al.. (1993). The application of fluorescent in situ hybridization to detect Mbcr/abl fusion in variant Ph chromosomes in CML and ALL. Cancer Genetics and Cytogenetics. 71(1). 7–14. 97 indexed citations
10.
Jalal, Syed M., Mark E. Law, Eric R. Christensen, Jack L. Spurbeck, & Gordon W. Dewald. (1993). Method for sequential staining of GTL‐banded metaphases with fluorescent‐labeled chromosome‐specific paint probes. American Journal of Medical Genetics. 46(1). 98–103. 19 indexed citations
11.
Dewald, Gordon W., et al.. (1992). Cytogenetic guidelines for fragile X studies tested in routine practice. American Journal of Medical Genetics. 44(6). 816–821. 9 indexed citations
12.
Herrmann, Marie A., Ian Hay, Jack L. Spurbeck, et al.. (1991). Cytogenetics of six follicular thyroid adenomas including a case report of an oxyphil variant with t(8;14)(q13;q24.1). Cancer Genetics and Cytogenetics. 56(2). 231–235. 8 indexed citations
13.
Jenkins, Robert B., Ian Hay, John F. Herath, et al.. (1990). Frequent occurrence of cytogenetic abnormalities in sporadic nonmedullary thyroid carcinoma. Cancer. 66(6). 1213–1220. 82 indexed citations
14.
Spurbeck, Jack L., et al.. (1988). Culturing and robotic harvesting of bone marrow, lymph nodes, peripheral blood, fibroblasts, and solid tumors with in situ techniques. Cancer Genetics and Cytogenetics. 32(1). 59–66. 61 indexed citations
15.
Dewald, Gordon W., Richard J. Dahl, Jack L. Spurbeck, J. Aidan Carney, & Hymie Gordon. (1987). Chromosomally Abnormal Clones and Nonrandom Telomeric Translocations in Cardiac Myxomas. Mayo Clinic Proceedings. 62(7). 558–567. 79 indexed citations
16.
Dewald, G.W., et al.. (1986). T-lymphocytes with 7;14 translocations: frequency of occurrence, breakpoints, and clinical and biological significance.. PubMed. 38(4). 520–32. 32 indexed citations
17.
Dewald, Gordon W., Pierre Noël, Richard J. Dahl, & Jack L. Spurbeck. (1985). Chromosome Abnormalities in Malignant Hematologic Disorders. Mayo Clinic Proceedings. 60(10). 675–689. 36 indexed citations
18.
Powell, Frank C., et al.. (1984). The Anticentromere Antibody: Disease Specificity and Clinical Significance. Mayo Clinic Proceedings. 59(10). 700–706. 39 indexed citations
19.
Dewald, Gordon W. & Jack L. Spurbeck. (1983). Sex Chromosome Anomalies Associated with Premature Gonadal Failure. Seminars in Reproductive Medicine. 1(2). 79–92. 5 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabrina Tosi Breakdown of academic impact, for papers by Josette Derré Breakdown of academic impact, for papers by Sheila N.J. Sait Breakdown of academic impact, for papers by A J Carroll Breakdown of academic impact, for papers by Gordon W. Dewald Breakdown of academic impact, for papers by Jacqueline R. Batanian Breakdown of academic impact, for papers by Carin Lassen Breakdown of academic impact, for papers by Ilse Chudoba Breakdown of academic impact, for papers by Zuzana Zemanová Breakdown of academic impact, for papers by Sverre Heim
Rankless by CCL
2026